WO2004017931A1 - Kosmetische oder dermatologische zubereitung mit proteinen zur hautaufhellung - Google Patents
Kosmetische oder dermatologische zubereitung mit proteinen zur hautaufhellung Download PDFInfo
- Publication number
- WO2004017931A1 WO2004017931A1 PCT/EP2003/009046 EP0309046W WO2004017931A1 WO 2004017931 A1 WO2004017931 A1 WO 2004017931A1 EP 0309046 W EP0309046 W EP 0309046W WO 2004017931 A1 WO2004017931 A1 WO 2004017931A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- copper
- preparation
- oxidase
- proteins
- weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Definitions
- the invention relates to a cosmetic or dermatological preparation with proteins or enzymes, which can be used to lighten skin.
- EP 909161 describes substituted diphenols in a water-in-silicone gel composition as skin lightening agents.
- the object of the invention is to provide new cosmetic or dermatological agents for lightening human skin. Another task is to influence the skin tanning process.
- the cosmetic or dermatological preparation comprises an effective content of modified copper-binding proteins or enzymes, which the copper in the prosthetic group was withdrawn by a previous exchange reaction, or on such modified copper-binding proteins, which were produced by recombinant processes without copper.
- the preparation preferably contains those copper-free modified copper-binding proteins which are selected from the group consisting of oxidoreductase, auracyanine, azurin, phytocyanine, plastocyanine, rusticyanine and mixtures thereof in their modified copper-free form.
- modified copper-binding enzymes include Cu, Zn-superoxide dismutase, dioxygenase, monooxygenase, amine oxidase, diaminooxidase, ascorbate oxidase, ceruloplasmin, cytochrome c-oxidase, galactose oxidase, lysyloxidase, catecholoxidase, N 2 O-reductase, tyneoxidase, haemocyaninase, haemocyaninase, haemocyaninase in their modified copper-free form.
- the content of the modified, essentially copper-free copper proteins is in the range from 0.001 to 1% by weight, preferably in the range from 0.005 to 0.01% by weight, based on the total weight of the preparation.
- copper proteins commonly referred to as “copper proteins” or “copper binding proteins” and. which are in their copper-containing form as blue or non-blue complexes, which contain Cu ions in their prosthetic group, the copper can be removed in a chelation reaction. You can also use recombinant methods and ter use of a copper-free molecule without the Cu ion.
- modified copper proteins are surprisingly able to effectively remove the copper from the enzyme tyrosinase, which is also a copper protein, and thus to interrupt the natural melanin synthesis, which takes place via the non-essential amino acid tyrosine.
- the chelation reaction with which, for example, the copper can be extracted from the copper proteins takes place in a known manner via cation exchangers or via chelating agents, such as polyoxycarboxylic acids, polyamines, ethylenediaminetetraacetic acid and their Na or K salts, nitrilotriacetic acid, etc.
- chelating agents such as polyoxycarboxylic acids, polyamines, ethylenediaminetetraacetic acid and their Na or K salts, nitrilotriacetic acid, etc.
- Such reactions are such Known specialist.
- azelaic acid, kojic acid or arbutin which also inhibit melanin synthesis
- azelaic acid, kojic acid or arbutin which also inhibit melanin synthesis
- the modified copper proteins are relatively easily accessible via a simple chelation reaction of commercially available protein or enzyme products.
- These can be obtained from plant extracts or by isolation from bacterial or yeast cultures and are then treated with a chelating agent.
- the preparation can additionally contain skin-lightening agents, so-called "whitening" agents, such as bearberry leaf extract, mustard seed extract of white mustard, white willow bark extract, hibiscus flower extract and mixtures thereof.
- skin-lightening agents so-called "whitening" agents, such as bearberry leaf extract, mustard seed extract of white mustard, white willow bark extract, hibiscus flower extract and mixtures thereof.
- whitening agents such as bearberry leaf extract, mustard seed extract of white mustard, white willow bark extract, hibiscus flower extract and mixtures thereof.
- whitening agents such as bearberry leaf extract, mustard seed extract of white mustard, white willow bark extract, hibiscus flower extract and mixtures thereof.
- reflective pigments selected from the group consisting of ground glass particles, TiO 2 / ZnO, mother-of-pearl, pearlescent pigments and mixtures thereof.
- ground white pearls with a particle size of 0.1-100 ⁇ m are added to the copper-binding proteins.
- Pearl proteins (conchagens) together with the copper-binding proteins result in an additional and surprisingly high brightening effect and a shine effect.
- the conchagens strengthen the glycoprotein anchoring in the skin and counteract the destabilization of the fiber network of the skin collagen, which results in an anti-aging effect.
- Ground pearls can be added in the range from 0.1 to 8% by weight.
- Glvcyrrhi a glabra is added or a complex consisting 5 from the root extract of Glycyrrhiza glabra, the root extract of Morus alba, the root extract of Scutellaria baicalensis, the extract of Saxifraga stolonifera) ' a grapefruit extract and disodium ethylenediaminetetraacetic acid (EDTA).
- EDTA disodium ethylenediaminetetraacetic acid
- UVB filters include -aminobenzoic acid derivatives such as 4- (dimethylamino) -benzoic acid (2-ethylhexyl) ester; Esters of cinnamic acid such as 4-methoxycinnamic acid (2-ethylhexyl) ester, benzophenone derivatives such as 2-hydroxy-4-methoxybenzophenone; 3-benzylidene
- Preferred oil-soluble UV filters are benzophenone-3, butyl methoxybenzoylmethane, octyl methoxycinnamate, octyl salicylate, 4-methylbenzylidene camphor, homosalate and octyl dimethyl PABA. 25
- Water-soluble UVB filters are e.g. Sulfonic acid derivatives of benzophenone or of 3-benzylidene camphor or salts such as the ⁇ a or the K salt of 2-phenylbenzimidazole-5-sulfonic acid.
- UVA filters include dibenzoylmethane derivatives such as l-phenyl-4- (4'-isopropylphenyl) prppan-1, 3-dione.
- a preferred amount of added organic UVA and / or UVB filter is in the range from 1 to 20% by weight, advantageously 1 35 to 12% by weight, in particular 1 to 3% by weight, based on the weight of the total composition.
- the preparation according to the invention further contains cosmetic auxiliaries and carriers, as are usually used in such preparations, for example water, preservatives, dyes, white pigments, thickeners, fragrances, alcohols, polyols, esters, electrolytes, gelling agents, polar and non-polar oils, Polymers, copolymers, emulsifiers, waxes, stabilizers.
- the preparation according to the invention can contain further cosmetic active ingredients.
- these include e.g. B. radical scavengers, humectants, vitamins, herbal agents, polymers, antioxidants, anti-inflammatory natural agents, oxygen-loaded asymmetric lamellar aggregates according to WO 94/00109; Digestion products of yeast or vegetable substances, produced by a gentle ultrasonic digestion process according to WO 94/13783; Kaolin; and kaolin modified with Si0 2 in accordance with W094 / 17588.
- the preparation can be in the form of an emulsion or a gel.
- suitable gelling agents include carbomer, xanthan gum, carrageenan, acacia, guar gourami, agar-agar, alginates and tyloses, carboxymethyl cellulose, hydroxyethyl cellulose, quaternized cellulose, quaternized guar, certain polyacrylates, polyvinyl alcohol, polyvinyl pyrrolidone, montmorillon.
- oils used for the invention can be conventional cosmetic oils, such as a mineral oil; hydrogenated polyisobutene; synthetic or natural squalane such as SynthesqualD, CosbiolD; cosmetic esters or ethers, which can be branched or unbranched, saturated or unsaturated; vegetable oils; or mixtures of two or more of them.
- cosmetic oils such as a mineral oil; hydrogenated polyisobutene; synthetic or natural squalane such as SynthesqualD, CosbiolD; cosmetic esters or ethers, which can be branched or unbranched, saturated or unsaturated; vegetable oils; or mixtures of two or more of them.
- oils are, for example, silicone oils, mineral oils, hydrogenated polyisobutene, polyisoprene, squalane, tridecyclyl trimellitate, trimethylpropane triisostearate, isodecyl citrate, neopentyl glycol diheptanoate, PPG-15 stearyl ether and vegetable oils, such as Rölöl, oil oil, avian oil oil, calendula oil, jojoba oil, avian oil oil, avian oil oil, Cocoa butter, coconut oil, corn oil, cottonseed oil, olive oil, palm kernel oil, rapeseed oil, safflower oil, sesame seed oil, soybean oil, sunflower seed oil, wheat germ oil, grape seed oil, coconut oil, safflower oil and mixtures thereof.
- silicone oils for example, silicone oils, mineral oils, hydrogenated polyisobutene, polyisoprene, squalane, tridecyclyl trimellitate, trimethylpropane triisostearate
- the cosmetic properties of the solid composition are influenced, such as degree of transparency, softness, hardness, spreading effect.
- Suitable humectants are e.g. Glycerin, butylene glycol, propylene glycol and mixtures thereof.
- a large number of compounds can normally be used as emollients, such as stearyl alcohol, glyceryl monoricinoleate, glyceryl monostearate, propane-1,2-diol, butane-1,3-diol, cetyl alcohol, isopropyl isostearate, stearic acid, isobutyl palmitate, isopropyl myristate, isopropyl palmitate Oley alcohol, isopropyl laurate, decyl oleate, octadecan-2-ol, isoctyl alcohol, cetyl palmitate, silicone oils such as dirnethyl polysiloxane, polyethylene glycol, lanolin, cocoa butter, vegetable oils such as corn oil, cottonseedol, olive oil, mineral oils, etc., butyl mymitate, butyl palmitate, butyl palmitate,
- phase A and B are each mixed separately at about 75 ° C, combined and homogenized. After cooling to about 40 ° C., the phase C assembled from the individual components at this temperature is added with stirring.
- the modified enzyme was produced at about 30 ° C. using EDTA.
- Example 2 Lightening and Shine Face Cream SPF 20 Phase A
- RPF active ingredient preparation * 0, 8 yeast extract ** 0, 1 azurin (Cu-free modified) 0, 1 glycyrrhiza glabra (Licorice) 0, 5 bearberry leaf extract 0, 1 white willow bark extract 0, 3 ground white pearls 0, 5-30 ⁇ m 1, 0 perfume oil 0, 1
- phase A and B are each mixed separately at about 75 ° C, combined and homogenized. After cooling to about 40 ° C., phase C, which is composed of the individual components at this temperature, is added with stirring.
- the modified azurin was prepared at about 28 ° C. using nitrilotriacetic acid.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003260420A AU2003260420A1 (en) | 2002-08-21 | 2003-08-15 | Cosmetic or dermatological preparation with skin-lightening proteins |
DE50307141T DE50307141D1 (de) | 2002-08-21 | 2003-08-15 | Kosmetische oder dermatologische zubereitung mit proteinen zur hautaufhellung |
EP03792321A EP1531782B1 (de) | 2002-08-21 | 2003-08-15 | Kosmetische oder dermatologische zubereitung mit proteinen zur hautaufhellung |
JP2004530152A JP2005537314A (ja) | 2002-08-21 | 2003-08-15 | 皮膚を明るくするタンパク質を用いる化粧用または皮膚科用製剤 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10239029A DE10239029A1 (de) | 2002-08-21 | 2002-08-21 | Kosmetische und dermatologische Zubereitung mit Proteinen zur Hautaufhellung |
DE10239029.0 | 2002-08-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004017931A1 true WO2004017931A1 (de) | 2004-03-04 |
Family
ID=31197380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/009046 WO2004017931A1 (de) | 2002-08-21 | 2003-08-15 | Kosmetische oder dermatologische zubereitung mit proteinen zur hautaufhellung |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1531782B1 (de) |
JP (1) | JP2005537314A (de) |
KR (1) | KR20050074429A (de) |
CN (1) | CN1326515C (de) |
AT (1) | ATE360458T1 (de) |
AU (1) | AU2003260420A1 (de) |
DE (2) | DE10239029A1 (de) |
ES (1) | ES2283862T3 (de) |
WO (1) | WO2004017931A1 (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009045798A1 (de) | 2009-10-19 | 2010-08-05 | Henkel Ag & Co. Kgaa | Enzymatische Hautaufhellung |
JP5152519B2 (ja) * | 2006-06-29 | 2013-02-27 | 大正製薬株式会社 | C−フェニル1−チオグルシト−ル化合物 |
US8716244B2 (en) | 2004-07-07 | 2014-05-06 | Sciotec Diagnostic Technologies Gmbh | Diaminooxidase-containing pharmaceutical compositions |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080138393A1 (en) * | 2006-12-11 | 2008-06-12 | Access To Business Group International Llc | Water soluble extract of spinach for prevention and repair of DNA damage |
KR101098581B1 (ko) * | 2009-01-09 | 2011-12-26 | 서울대학교산학협력단 | Abh 항원을 이용한 염증질환 개선용 조성물 |
CN104688652A (zh) * | 2015-03-17 | 2015-06-10 | 欧诗漫生物股份有限公司 | 一种用于美白皮肤的化妆品组合物及其制备方法 |
CN105963182A (zh) * | 2016-05-30 | 2016-09-28 | 李建东 | 一种清亮滋养柔肤面膜液及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5609875A (en) * | 1994-03-17 | 1997-03-11 | Fischer Pharmaceuticals Ltd. | Skin whitening composition |
FR2742661A1 (fr) * | 1995-12-21 | 1997-06-27 | Texinfine Sa | Nouvelle utilisation de compositions contenant de la nacre |
WO1998019665A1 (en) * | 1996-11-04 | 1998-05-14 | The Procter & Gamble Company | Skin lightening compositions |
US6197304B1 (en) * | 1997-09-12 | 2001-03-06 | Coreana Cosemetics Co., Ltd. | Whitening cosmetics containing solvent-fractionated extracts of ramulus mori extract |
WO2003047543A1 (en) * | 2001-10-05 | 2003-06-12 | Procyte Corporation | Methods for the treatment of hyperpigmentation of skin |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2777193B1 (fr) * | 1998-04-14 | 2001-06-08 | Coletica | Particule a groupement hydroxamique chelatante d'ions metalliques et leur utilisation en cosmetique ou en pharmacie |
JP4233734B2 (ja) * | 2000-07-19 | 2009-03-04 | 株式会社資生堂 | 美白用皮膚外用剤 |
-
2002
- 2002-08-21 DE DE10239029A patent/DE10239029A1/de not_active Withdrawn
-
2003
- 2003-08-15 AU AU2003260420A patent/AU2003260420A1/en not_active Abandoned
- 2003-08-15 CN CNB038195747A patent/CN1326515C/zh not_active Expired - Fee Related
- 2003-08-15 KR KR1020057000631A patent/KR20050074429A/ko not_active Application Discontinuation
- 2003-08-15 ES ES03792321T patent/ES2283862T3/es not_active Expired - Lifetime
- 2003-08-15 AT AT03792321T patent/ATE360458T1/de not_active IP Right Cessation
- 2003-08-15 WO PCT/EP2003/009046 patent/WO2004017931A1/de active IP Right Grant
- 2003-08-15 JP JP2004530152A patent/JP2005537314A/ja active Pending
- 2003-08-15 DE DE50307141T patent/DE50307141D1/de not_active Expired - Lifetime
- 2003-08-15 EP EP03792321A patent/EP1531782B1/de not_active Expired - Lifetime
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5609875A (en) * | 1994-03-17 | 1997-03-11 | Fischer Pharmaceuticals Ltd. | Skin whitening composition |
FR2742661A1 (fr) * | 1995-12-21 | 1997-06-27 | Texinfine Sa | Nouvelle utilisation de compositions contenant de la nacre |
WO1998019665A1 (en) * | 1996-11-04 | 1998-05-14 | The Procter & Gamble Company | Skin lightening compositions |
US6197304B1 (en) * | 1997-09-12 | 2001-03-06 | Coreana Cosemetics Co., Ltd. | Whitening cosmetics containing solvent-fractionated extracts of ramulus mori extract |
WO2003047543A1 (en) * | 2001-10-05 | 2003-06-12 | Procyte Corporation | Methods for the treatment of hyperpigmentation of skin |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8716244B2 (en) | 2004-07-07 | 2014-05-06 | Sciotec Diagnostic Technologies Gmbh | Diaminooxidase-containing pharmaceutical compositions |
US9364437B2 (en) | 2004-07-07 | 2016-06-14 | Sciotec Diagnostic Technologies Gmbh | Diaminooxidase-containing pharmaceutical compositions |
JP5152519B2 (ja) * | 2006-06-29 | 2013-02-27 | 大正製薬株式会社 | C−フェニル1−チオグルシト−ル化合物 |
DE102009045798A1 (de) | 2009-10-19 | 2010-08-05 | Henkel Ag & Co. Kgaa | Enzymatische Hautaufhellung |
Also Published As
Publication number | Publication date |
---|---|
KR20050074429A (ko) | 2005-07-18 |
JP2005537314A (ja) | 2005-12-08 |
ES2283862T3 (es) | 2007-11-01 |
CN1674857A (zh) | 2005-09-28 |
DE10239029A1 (de) | 2004-03-04 |
CN1326515C (zh) | 2007-07-18 |
ATE360458T1 (de) | 2007-05-15 |
EP1531782B1 (de) | 2007-04-25 |
DE50307141D1 (de) | 2007-06-06 |
EP1531782A1 (de) | 2005-05-25 |
AU2003260420A1 (en) | 2004-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1185244B1 (de) | Enzymhaltiges kosmetikum | |
EP1324747B1 (de) | Kosmetische zubereitung mit pflanzenextrakten | |
US20050063932A1 (en) | Skin care compositions including hexapeptide complexes and methods of their manufacture | |
EP1640042B1 (de) | Kosmetisches Aufhellungs- und Reinigungsmittel für die Haut enthaltend Extrakte aus Lotus, Kiwi, Orchideen und Süssholz | |
EP1804923B1 (de) | Feuchtigkeitsregulierendes kosmetikum | |
DE10231468A1 (de) | Anti-Hautalterungskosmetikum | |
KR20080079126A (ko) | 알로에신 및 감초 추출물을 포함하는 미백용 화장료 조성물 | |
CN113893217A (zh) | 一种具有淡斑功效的面霜组合物及其制备方法和应用 | |
EP1531782B1 (de) | Kosmetische oder dermatologische zubereitung mit proteinen zur hautaufhellung | |
DE102004054926B3 (de) | Kosmetisches Hautmattierungsmittel | |
KR20100006796A (ko) | 생약 발효 추출물을 포함하는 피부 노화 방지 화장료조성물 | |
EP1648568B1 (de) | Kosmetikum zur depigmentierung | |
JP4035481B2 (ja) | 皮膚外用剤 | |
JP2971549B2 (ja) | 化粧料 | |
DE102004010645A1 (de) | Kosmetikum zur Depigmentierung | |
KR100829819B1 (ko) | 판두라틴 유도체를 함유하는 피부 미백용 화장료 조성물 | |
EP1855635B1 (de) | Kosmetisches präparat zur bräunungsverlängerung | |
CN109199988B (zh) | 一种美白护肤品及其制备方法 | |
JP7233832B2 (ja) | 毛髪化粧料 | |
JP3471856B2 (ja) | 養毛料 | |
JPH09175980A (ja) | 化粧料 | |
EP1696869A1 (de) | Kosmetisches bräunungsmittel auf basis von dihydroxyaceton | |
DE102023203790A1 (de) | Kosmetische oder dermatologische Zubereitungen zur Prophylaxe und Linderung der erythropoetischen Protoporphyrie | |
JP2008037819A (ja) | 化粧料 | |
JP2020186204A (ja) | 皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WD | Withdrawal of designations after international publication |
Free format text: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020057000631 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004530152 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038195747 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003792321 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003792321 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057000631 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 2003792321 Country of ref document: EP |